Publication: Results of treatment in stage IIB squamous cell carcinoma of the uterine cervix: Comparison between two and one intracavitary insertion
Issued Date
1992-01-01
Resource Type
ISSN
10956859
00908258
00908258
Other identifier(s)
2-s2.0-0026749887
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Gynecologic Oncology. Vol.45, No.2 (1992), 160-163
Suggested Citation
Puangtong Kraiphibul, Somkeart Srisupundit, Virat Pairachvet, Somjai Kiatgumjaikajorn, Chirapha Tannanonta Results of treatment in stage IIB squamous cell carcinoma of the uterine cervix: Comparison between two and one intracavitary insertion. Gynecologic Oncology. Vol.45, No.2 (1992), 160-163. doi:10.1016/0090-8258(92)90279-R Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/22431
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Results of treatment in stage IIB squamous cell carcinoma of the uterine cervix: Comparison between two and one intracavitary insertion
Other Contributor(s)
Abstract
To compare the results of treatment in stage IIB squamous cell carcinoma of the uterine cervix of two treatment regimens, two radium insertions vs one insertion, a prospective randomized study was carried out at Ramathibodi Hospital from 1 January 1983 to 31 December 1986, and the results were evaluated at the end of March 1991. The patients in treatment I (90 cases) received 40-41.4 Gy whole pelvic external irradiation and two intracavitary radium insertions, while patients in treatment II (53 cases) received 50.0-50.4 Gy and one intracavitary insertion. Both groups received the same total dose at point A, about 85-90 Gy. At 4 and 5 years, by the Kaplan-Meier survival curve, the diseasefree survivals were 76 and 76% vs 79 and 79%, respectively, in treatment I and treatment II, which showed no significant difference by the log-rank test. Both groups had comparable serious complication rates, 0% vs 1.9%, respectively. However, grade I complications in treatment II, 35.8%, were higher than those in treatment I, 17.8% (P < 0.01). Therefore, we concluded that treatment II provided the same disease-free survival and a very low rate of serious complications. To replace treatment I, the dose at the rectum and urinary bladder should be maintained with caution. © 1992.